RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against REGENXBIO Inc. and is encouraging investors who suffered losses to discuss their legal options [1] Group 1 - The investigation pertains to securities purchased or acquired in REGENXBIO between February 9, 2022, and January 27, 2026 [1] - There is a deadline of April 14, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against REGENXBIO [1]